Clinical Trials Browser

Phase 2/3 × Breast × 90 days × Clear all

NCT06062810 2026-04-09

Drugs-SNPs

Phase 2/3 Active not recruiting

Breast Neoplasms

NCT07413939 2026-04-09

BREnnA

Phase 2/3 Not yet recruiting

HER2-positive Breast Cancer

NCT04715958 2026-04-06

SHAPE Neoadjuvant Chemotherapy Response

Phase 2/3 Recruiting

Anatomic Stage III Breast Cancer AJCC v8

NCT03315364 2026-04-01

OPTIMAL

Phase 2/3 Active not recruiting

Breast Neoplasms, Recurrence

NCT06926868 2026-04-01

A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

Phase 2/3 Recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07294508 2026-03-20

A Study to Evaluate HLX22 in Combination With HLX87 in Patients With HER2-Positive Recurrent or Metastatic Breast Cancer

Phase 2/3 Recruiting

Breast Neoplasms

NCT04191499 2026-03-17

INAVO120

Phase 2/3 Active not recruiting

325 enrolled 14 charts 3 FDA

Breast Neoplasms

NCT05766891 2026-03-16

Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery

Phase 2/3 Recruiting

Breast Neoplasms

NCT03077841 2026-03-05

Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer

Phase 2/3 Suspended

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT07410169 2026-02-13

Efficacy and Safety of Hyperbaric Oxygen Therapy in Improving Nab-paclitaxel-Induced Peripheral Neuropathy

Phase 2/3 Not yet recruiting

Breast Neoplasms

NCT06009627 2026-02-10

Study of Neoadjuvant Endocrine Therapy in HR Positive and HER2 Negative Premenopausal Breast Cancer Patients

Phase 2/3 Completed

Breast Neoplasms

NCT07373782 2026-01-28

Continuous Positive Airway Pressure (CPAP) Assisted Radiotherapy in Breast Cancer

Phase 2/3 Recruiting

Microcephaly, Primary Autosomal Recessive, 6, Breast Neoplasms

NCT07366840 2026-01-26

BRIGHT

Phase 2/3 Not yet recruiting

Breast Neoplasms